Dynamic Technology Lab Private LTD Corbus Pharmaceuticals Holdings, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $49,844 - $72,463	-10,235 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $67,551 - $79,833	10,235 New	10,235 $71,000
Q1 2019 May 13, 2019	SELL	$5.76 - $8.95 $100,160 - $155,631	-17,389 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$5.26 - $7.97 $91,466 - $138,590	17,389 New	17,389 $102,000
Q1 2018 May 14, 2018	SELL	$5.6 - $9.25 $121,284 - $200,336	-21,658 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$6.6 - $7.78 $142,942 - $168,499	21,658 New	21,658 $154,000
Q3 2017 Nov 08, 2017	SELL	$5.75 - $7.75 $180,728 - $243,590	-31,431 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	31,431	31,431 $198,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.2B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.